RÉSUMÉ DIGEST
ACT 189 (HB 174) 2015 Regular Session LeBas
Existing law provides for the designation of controlled dangerous substances into Schedules
I, II, III, IV, and V based upon the substances' potential for addiction and abuse.
New law adds two substances to Schedule IV.
Prior law provided that hydrocodone was a Schedule II drug, but was a Schedule III drug
when found in combination with other substances.
New law repeals the Schedule III classification for hydrocodone combination products to
make La. law consistent with federal scheduling classifications.
Existing law provides that a pharmacist cannot dispense more than a 10-day supply at a
dosage not to exceed the FDA's approved labeling for the medication if the prescriber for
such medication is not licensed by the state of Louisiana, and the medication is an opioid
derivative Schedule II or Schedule III controlled dangerous substance. Existing law further
provides that the dispensing pharmacist must notify the prescriber of the supply dispensed
and the cancellation of the remainder of the prescription. Existing law further provides that
within 60 days of the dispensing of a medication pursuant to existing law, such medication
cannot be dispensed again for the individual by a prescriber not licensed by the state of
Louisiana.
New law adds that restrictions of existing law regarding the dispensing of Schedule II and
Schedule III opioids do not apply if the prescription monitoring information from the state
of the prescriber may be viewed by the dispensing pharmacist.
Effective June 23, 2015.
(Amends R.S. 40:978(E); Adds R.S. 40:964(Schedule IV)(A)(3) and (B)(45.5); Repeals R.S.
40:964(Schedule III)(D)(1)(c) and (d))
Page 1 of 1